Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genomics, cell therapy could be future topics for regulatory harmonization, Glaxo chairman tells ICH 4.

Executive Summary

GENOMICS REGULATION HARMONIZATION IS POSSIBLE NEW FOCUS FOR ICH, Glaxo Wellcome Chairman Richard Sykes suggested at the fourth International Conference on Harmonization meeting in Brussels July 16. The development of gene therapies and genetic testing raise regulatory questions that have not yet been addressed, Sykes said, presenting an opportunity to create harmonized regulations as the state of technology advances.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030572

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel